NCT06171074View on ClinicalTrials.gov

Study of CM310 in Subjects With Seasonal Allergic Rhinitis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

March 30, 2025

Study Completion Date

March 30, 2025

Conditions
Seasonal Allergic Rhinitis
Interventions
BIOLOGICAL

CM310

CM310 injection

Trial Locations (1)

Unknown

Beijing Tong-Ren hospital, Beijing

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06171074 - Study of CM310 in Subjects With Seasonal Allergic Rhinitis | Biotech Hunter | Biotech Hunter